Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Therapeutic drug monitoring is advised in all the following drugs except?

Metformin. Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **therapeutic window** [1]. It is indicated for drugs with a narrow therapeutic index, unpredictable pharmacokinetics, or where toxicity is difficult to distinguish from the disease process. **Why Metformin is the correct answer:** Metformin has a **wide therapeutic index** and its clinical effect (blood glucose levels) can be easily monitored using pharmacodynamic markers like HbA1c or fasting blood glucose [4]. There is no established correlation between plasma metformin levels and its glucose-lowering effect or the risk of lactic acidosis. Therefore, TDM is not required. **Why the other options are incorrect:** * **Phenytoin:** It follows **zero-order (non-linear) kinetics** at high therapeutic doses [2]. Small dose increments can lead to disproportionately large increases in plasma levels, causing neurotoxicity (ataxia, nystagmus) [5]. * **Tacrolimus & Cyclosporine:** These are **calcineurin inhibitors** used in organ transplants. They have a very narrow therapeutic window; sub-therapeutic levels lead to graft rejection, while supra-therapeutic levels cause significant nephrotoxicity and neurotoxicity [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Narrow therapeutic index (Lithium, Digoxin, Aminoglycosides), drugs with saturable metabolism (Phenytoin), and to check compliance [2]. * **Drugs NOT requiring TDM:** Drugs whose effects are easily measured (Antihypertensives, Hypoglycemics, Anticoagulants like Warfarin—monitored via PT/INR) [4], and "hit and run" drugs (Omeprazole). * **Lithium** is the most common drug requiring TDM in psychiatry (Target: 0.6–1.2 mEq/L). * **Digoxin** TDM is done at least 6–8 hours after the last dose to allow for tissue distribution.

Q: Which of the following is not an ototoxic drug?

Paracetamol. **Explanation:** **1. Why Paracetamol is the Correct Answer:** Paracetamol (Acetaminophen) is a non-opioid analgesic and antipyretic that is generally considered safe for the auditory system. Unlike Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like Aspirin, which can cause reversible tinnitus and hearing loss at high doses, Paracetamol does not possess significant ototoxic properties and does not damage the cochlear hair cells or the stria vascularis. **2. Analysis of Incorrect Options (Ototoxic Drugs):** * **Cisplatin:** A potent chemotherapeutic agent known for causing **permanent, bilateral, high-frequency sensorineural hearing loss (SNHL)**. It causes damage by generating free radicals that destroy the outer hair cells of the Organ of Corti. * **Quinine:** Used in the treatment of malaria and nocturnal muscle cramps. It causes "Cinchonism," characterized by reversible SNHL and tinnitus. It primarily affects the enzyme systems within the cochlea. * **Erythromycin:** While most macrolides are safe, intravenous high-dose Erythromycin (especially in patients with renal or hepatic failure) can cause **reversible SNHL**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycosides:** The most common cause of drug-induced ototoxicity. **Gentamicin/Streptomycin** are primarily vestibulotoxic, while **Amikacin/Neomycin/Kanamycin** are primarily cochleotoxic. * **Loop Diuretics:** (e.g., Furosemide, Ethacrynic acid) cause edema of the stria vascularis, leading to usually reversible hearing loss. * **Salicylates (Aspirin):** Characteristically cause high-pitched tinnitus and reversible SNHL. * **Topical Ototoxicity:** Avoid using aminoglycoside ear drops in the presence of a tympanic membrane perforation to prevent damage to the inner ear via the round window.

Q: Which of the following is a monovalent cation that can reverse a digitalis-induced arrhythmia?

Potassium. **Explanation:** **Mechanism of the Correct Answer:** Digitalis (Digoxin) works by inhibiting the **Na+/K+-ATPase pump**. In toxicity, excessive inhibition leads to intracellular potassium depletion and extracellular hyperkalemia (in acute cases). However, **Potassium (Option D)** is the specific **monovalent cation** used to reverse arrhythmias. Potassium acts by: 1. **Competitive Inhibition:** It competes with digoxin for binding sites on the Na+/K+-ATPase pump. Increasing extracellular potassium promotes the dissociation of digoxin from the enzyme. 2. **Electrophysiology:** It decreases abnormal automaticity in the Purkinje fibers, which is the primary cause of digitalis-induced tachyarrhythmias. **Analysis of Incorrect Options:** * **A. Digibind antibodies:** While these are the definitive treatment for life-threatening digoxin toxicity, they are **proteins (Fab fragments)**, not monovalent cations. * **B. Lidocaine:** This is the drug of choice for digitalis-induced ventricular arrhythmias, but it is a **local anesthetic/Class IB antiarrhythmic**, not a cation. * **C. Magnesium:** This is a **divalent cation** ($Mg^{2+}$). It is highly effective in treating digitalis-induced arrhythmias (especially if hypomagnesemia is present), but it does not fit the "monovalent" criteria. **High-Yield Clinical Pearls for NEET-PG:** * **Hypokalemia** predisposes to digoxin toxicity because there is less competition for the pump binding sites. * **Hyperkalemia** is a marker of **acute** severe digitalis poisoning (prognostic indicator). * **Classic ECG sign:** "Reverse Tick" or "Sagging" ST-segment depression (Salvador Dali sign). * **Contraindication:** Never use **Calcium** in digoxin toxicity ("Stone Heart" phenomenon).

Q: Which of the following is NOT a manifestation of anaphylactic shock?

Vasoconstriction. **Explanation:** Anaphylactic shock is a **Type I Hypersensitivity reaction** mediated by IgE antibodies, leading to the massive release of histamine and other inflammatory mediators (like leukotrienes and prostaglandins) from mast cells and basophils. **Why Vasoconstriction is the Correct Answer:** The hallmark of anaphylaxis is **systemic vasodilation** (not vasoconstriction). Histamine acts on H1 and H2 receptors in the vascular smooth muscle, causing profound peripheral vasodilation and increased capillary permeability. This leads to a relative hypovolemia and a "distributive" shock. Therefore, vasoconstriction is physiologically opposite to what occurs in anaphylaxis. **Analysis of Incorrect Options:** * **Hypotension:** This occurs due to the sudden decrease in systemic vascular resistance (vasodilation) and the leakage of fluid into the extravascular space (third-spacing). * **Bronchospasm:** Histamine and leukotrienes cause contraction of the bronchial smooth muscle, leading to wheezing and respiratory distress. * **Laryngeal Edema:** Increased capillary permeability causes rapid swelling of the upper airway tissues, which is a life-threatening cause of airway obstruction in anaphylaxis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice:** **Adrenaline (Epinephrine)** is the first-line treatment. It acts as a physiological antagonist. 2. **Mechanism of Adrenaline:** It causes **vasoconstriction (α1)** to reverse hypotension, **bronchodilation (β2)** to relieve bronchospasm, and inhibits further mediator release (β2). 3. **Route & Dose:** The preferred route is **Intramuscular (IM)** in the anterolateral thigh. The standard dose is **0.5 mg (1:1000 concentration)** for adults. 4. **Biphasic Reaction:** Symptoms can recur 1–72 hours after initial resolution; hence, patients should be monitored.

Q: Hypoglycemia caused by anti-hyperglycemic drugs like sulfonylureas can be classified as which type of adverse drug reaction?

Type A. **Explanation:** Adverse Drug Reactions (ADRs) are most commonly classified using the **Rawlins and Thompson classification**. **1. Why Option A is Correct:** **Type A (Augmented)** reactions are dose-dependent, predictable based on the known pharmacology of the drug, and have high morbidity but low mortality. * **Mechanism:** Sulfonylureas (e.g., Glimepiride) work by stimulating insulin release from pancreatic beta cells. Hypoglycemia is a direct, exaggerated extension of this intended pharmacological action. If the dose is too high or the patient fasts, the drug "over-performs," leading to low blood glucose. **2. Why Other Options are Incorrect:** * **Type B (Bizarre):** These are unpredictable, dose-independent, and not related to the drug's known action (e.g., Anaphylaxis with Penicillin or Stevens-Johnson Syndrome). * **Type C (Chronic/Continuous):** These occur due to long-term drug use (e.g., Analgesic nephropathy or Iatrogenic Cushing’s syndrome from steroids). * **Type D (Delayed):** These manifest long after the drug exposure, such as teratogenicity (e.g., Thalidomide) or carcinogenicity. **Clinical Pearls for NEET-PG:** * **Type E (End-of-use):** Withdrawal symptoms (e.g., seizures after stopping Benzodiazepines). * **Type F (Failure):** Unexpected failure of therapy (e.g., drug interactions reducing the efficacy of Oral Contraceptive Pills). * **High-Yield Fact:** Most ADRs (approx. 80%) encountered in clinical practice are **Type A**, making them preventable by dosage adjustment.

Q: Pralidoxime acts by?

Reactivating cholinesterase enzyme. ### Explanation **Correct Option: A. Reactivating cholinesterase enzyme** Pralidoxime (2-PAM) is a **cholinesterase reactivator** used in the treatment of organophosphate (OP) poisoning. Organophosphates inhibit the enzyme Acetylcholinesterase (AChE) by phosphorylating its esteratic site, leading to a toxic accumulation of acetylcholine. Pralidoxime has a high affinity for the phosphorus atom; it binds to the anionic site of the enzyme, nucleophilically attacks the phosphate group, and pulls it away. This releases the free, functional enzyme, allowing it to resume the breakdown of acetylcholine. **Why the other options are incorrect:** * **B & C:** Pralidoxime does not influence the genetic expression or cellular machinery required for the **synthesis** of enzymes or neurotransmitters. Its action is purely biochemical and focused on the existing inhibited enzyme. * **D:** Pralidoxime does not have significant agonist or antagonist activity at nicotinic or muscarinic receptors. Its clinical benefit is indirect, mediated through the restoration of endogenous enzyme activity. **High-Yield Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Pralidoxime must be administered early. Once the enzyme-toxin bond undergoes "aging" (dealkylation), the bond becomes permanent, and oximes can no longer reactivate the enzyme. * **Blood-Brain Barrier:** Pralidoxime is a quaternary ammonium compound and **does not cross the BBB**. Therefore, it is ineffective against the central nervous system effects of OP poisoning (Atropine is required for CNS symptoms). * **Specific Utility:** It is highly effective at the **Neuromuscular Junction (NMJ)**, helping reverse skeletal muscle paralysis and fasciculations, which Atropine cannot do. * **Contraindication:** Oximes are generally avoided in **Carbamate poisoning**, as the enzyme-carbamate bond is reversible and oximes may paradoxically worsen the inhibition.

Q: Development of hepatic central lobular necrosis secondary to acetaminophen overdose can be prevented effectively by which of the following if given within a few hours after ingestion?

N-acetylcysteine. **Explanation:** The correct answer is **N-acetylcysteine (NAC)**. Acetaminophen (Paracetamol) toxicity occurs when its primary metabolic pathways (glucuronidation and sulfation) become saturated. A minor portion is then metabolized by **CYP2E1** into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*). Under normal conditions, NAPQI is neutralized by **Glutathione**. In overdose, glutathione stores are depleted, leading to NAPQI-induced oxidative stress and **centrilobular hepatic necrosis**. **N-acetylcysteine** acts as a life-saving antidote through two mechanisms: 1. It serves as a precursor for **Glutathione** synthesis. 2. It can directly bind to and detoxify NAPQI. It is most effective when administered within **8–10 hours** of ingestion. **Why other options are incorrect:** * **Dimercaprol (BAL):** A chelating agent used primarily for heavy metal poisoning (Arsenic, Mercury, and Lead). * **Sodium Nitrite & Amyl Nitrite:** These are components of the classic "Cyanide Antidote Kit." They induce **methemoglobinemia**, which has a high affinity for cyanide, diverting it away from cytochrome oxidase. **High-Yield NEET-PG Pearls:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma acetaminophen levels and time since ingestion. * **Chronic Alcoholics:** Are at higher risk of toxicity even with lower doses because alcohol induces **CYP2E1** and depletes baseline glutathione. * **NAC Administration:** Can be given IV or orally. The oral protocol typically lasts 72 hours, while the IV protocol (Acetadote) is 21 hours.

Q: Bland cholestasis is caused by all of the following drugs, except?

Chlorpromazine. ### Explanation The correct answer is **Chlorpromazine**. **1. Understanding the Concept: Bland vs. Inflammatory Cholestasis** Drug-induced cholestasis is broadly categorized into two types based on the presence or absence of inflammation: * **Bland Cholestasis:** Characterized by bile stasis in the canaliculi with **minimal or no hepatocellular inflammation** or necrosis. On lab tests, bilirubin is elevated, but transaminases (ALT/AST) remain near normal. * **Inflammatory (Hepatocanalicular) Cholestasis:** Characterized by bile stasis accompanied by **portal inflammation** and focal necrosis. **2. Why Chlorpromazine is the Correct Answer** Chlorpromazine is the classic example of **Inflammatory Cholestasis**. It causes a hypersensitivity-type reaction leading to "Hepatocanalicular" injury. Patients typically present with fever, rash, and significant elevations in Alkaline Phosphatase (ALP) along with inflammatory changes on biopsy. **3. Why the Other Options are Incorrect** * **Androgens (e.g., Methyltestosterone):** These are the prototypical cause of **Bland Cholestasis**. They interfere with bile acid transporters without causing cell death or inflammation. [1] * **Oral Contraceptive Pills (OCPs):** Estrogens in OCPs decrease bile flow by affecting the Na+/K+-ATPase pump and canalicular membrane fluidity, leading to **Bland Cholestasis** (often seen as jaundice in pregnancy). * **Cyclosporine:** This immunosuppressant inhibits the Bile Salt Export Pump (BSEP), leading to dose-dependent **Bland Cholestasis**. **4. NEET-PG High-Yield Pearls** * **Bland Cholestasis Mnemonic:** **"ABC"** – **A**ndrogens, **B**irth control pills (OCPs), **C**yclosporine. * **Chlorpromazine** is also associated with "Vanishing Bile Duct Syndrome" in chronic cases. * **Anabolic steroids** (Androgens) are also uniquely associated with **Peliosis Hepatis** (blood-filled cysts in the liver).

Q: Which of the following substances is generally not considered amenable to removal by dialysis?

All of the above. **Explanation:** The effectiveness of hemodialysis in removing a toxin depends on specific pharmacokinetic properties. For a substance to be "dialyzable," it must have a **low molecular weight**, **low protein binding**, and, most importantly, a **low Volume of Distribution (Vd)**. **Why "All of the Above" is Correct:** The substances listed share characteristics that make them resistant to dialysis: * **Amphetamines:** These possess a very **large Volume of Distribution** (approx. 3–5 L/kg). They distribute extensively into tissues, meaning very little of the drug remains in the plasma to be filtered by the dialysis machine. * **Digoxin:** This is a classic high-yield example of a non-dialyzable drug. It has an **extremely large Vd** (approx. 5–7 L/kg) because it binds strongly to cardiac and skeletal muscle [3]. Furthermore, it has a long half-life and slow redistribution. * **Propranolol:** While it has a smaller molecular weight, it is **highly protein-bound** (>90%) and has a **high Vd**. Dialysis membranes cannot effectively filter drugs that are bound to large plasma proteins like albumin. **High-Yield NEET-PG Clinical Pearls:** * **Mnemonic for Dialyzable Drugs (BLAST-M):** **B**arbiturates (Phenobarbital), **L**ithium, **A**lcohols (Ethanol, Methanol, Ethylene glycol), **S**alicylates (Aspirin), **T**heophylline, and **M**etformin [1], [3]. * **Vd Rule:** If the Volume of Distribution is **>1 L/kg**, dialysis is generally ineffective [3]. * **Management Tip:** For Digoxin toxicity, the definitive treatment is **Digoxin-specific antibody fragments (DigiFab)**, not dialysis. For Propranolol/Beta-blocker overdose, the antidote of choice is **Glucagon** [2].

Q: Which of the following medications is contraindicated in patients with allergy to sulphonamides?

Brinzolamide. **Explanation:** **Brinzolamide** is the correct answer because it is a **topical Carbonic Anhydrase Inhibitor (CAI)**. Chemically, all carbonic anhydrase inhibitors (including acetazolamide, dorzolamide, and brinzolamide) are **sulfonamide derivatives**. In patients with a known hypersensitivity to sulfonamides, these drugs can trigger similar allergic reactions, ranging from localized rashes to severe systemic responses like Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), even when administered topically as eye drops. **Analysis of Incorrect Options:** * **Levobunolol (Option A):** This is a non-selective **beta-blocker**. It does not contain a sulfonamide moiety and is not contraindicated in sulfa-allergic patients. * **Bimatoprost (Option B):** This is a **prostaglandin analog** (prostamide). It works by increasing uveoscleral outflow and has no chemical structural relationship to sulfonamides. * **Brimonidine (Option D):** This is a highly selective **alpha-2 adrenergic agonist**. While it is known for causing local ocular allergy (follicular conjunctivitis), it does not cross-react with sulfonamides. **High-Yield Clinical Pearls for NEET-PG:** * **Cross-Reactivity Rule:** Always screen for sulfa allergy before prescribing CAIs, Loop diuretics (Furosemide), Thiazides, and Sulfonylureas. * **Exception:** Silver sulfadiazine (used in burns) and Mafenide acetate are also sulfonamides; however, **Sulfadiazine** is the specific sulfa drug most commonly associated with crystalluria. * **Brinzolamide vs. Dorzolamide:** Brinzolamide is often preferred over dorzolamide because it is a suspension with a neutral pH, causing less stinging/burning upon instillation.

Question 1

Therapeutic drug monitoring is advised in all the following drugs except?

Accepted Answer

Metformin

Answer

Phenytoin

Answer

Tacrolimus

Answer

Cyclosporine

Question 2

Which of the following is not an ototoxic drug?

Accepted Answer

Paracetamol

Answer

Cisplatin

Answer

Quinine

Answer

Erythromycin

Question 3

Which of the following is a monovalent cation that can reverse a digitalis-induced arrhythmia?

Accepted Answer

Potassium

Answer

Digibind antibodies

Answer

Lidocaine

Answer

Magnesium

Question 4

Which of the following is NOT a manifestation of anaphylactic shock?

Accepted Answer

Vasoconstriction

Answer

Hypotension

Answer

Bronchospasm

Answer

Laryngeal edema

Question 5

Hypoglycemia caused by anti-hyperglycemic drugs like sulfonylureas can be classified as which type of adverse drug reaction?

Accepted Answer

Type A

Answer

Type B

Answer

Type C

Answer

Type D

Question 6

Pralidoxime acts by?

Accepted Answer

Reactivating cholinesterase enzyme

Answer

Promoting synthesis of cholinesterase

Answer

Promoting synthesis of acetylcholine

Answer

Direct action on cholinergic receptors

Question 7

Development of hepatic central lobular necrosis secondary to acetaminophen overdose can be prevented effectively by which of the following if given within a few hours after ingestion?

Accepted Answer

N-acetylcysteine

Answer

Dimercaprol

Answer

Sodium nitrite

Answer

Amyl nitrite

Question 8

Bland cholestasis is caused by all of the following drugs, except?

Accepted Answer

Chlorpromazine

Answer

Androgen

Answer

OCP

Answer

Cyclosporine

Question 9

Which of the following substances is generally not considered amenable to removal by dialysis?

Accepted Answer

All of the above

Answer

Amphetamine

Answer

Digoxin

Answer

Propranolol

Question 10

Which of the following medications is contraindicated in patients with allergy to sulphonamides?

Accepted Answer

Brinzolamide

Answer

Levobunolol

Answer

Bimatoprost

Answer

Brimonidine

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?